Bright Minds Biosciences Inc.
DRUGFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Bright Minds Biosciences Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Sep 30, 2025. The latest insider filing shown is dated Apr 30, 2026. The latest institutional report shown is dated Dec 31, 2022; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| StoneX Group Inc. | 2022-12-31 | 10,193 | Not shown | SEC filing |
- Each value is checked against Bright Minds Biosciences Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: no share price from within three months of its report date is on file, so it could not be checked.
1 filer has only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Bright Minds Biosciences Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-11-04 · Cormorant Asset Management, LP: Larger than 10 of the 11 other insider purchases of Common Shares on file. SEC filing
- 2024-10-15 · Cormorant Asset Management, LP: Larger than all 11 other insider purchases of Common Shares on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-28 | Cormorant Asset Management, LP · Other | Common Shares | S — Open market or private sale | −109,331 | 89.50 | SEC filing |
| 2024-11-04 | Cormorant Asset Management, LP · 10% owner | Common Shares | P — Open market or private purchase | +184,331 | 21.70 | SEC filing |
| 2024-10-16 | Cormorant Asset Management, LP · 10% owner | Common Shares | P — Open market or private purchase | +7,150 | 24.03 | SEC filing |
| 2024-10-16 | Cormorant Asset Management, LP · 10% owner | Common Shares | P — Open market or private purchase | +3,107 | 25.22 | SEC filing |
| 2024-10-16 | Cormorant Asset Management, LP · 10% owner | Common Shares | P — Open market or private purchase | +39,743 | 23.22 | SEC filing |
| 2024-10-15 | Cormorant Asset Management, LP · 10% owner | Common Shares | P — Open market or private purchase | +238,097 | 4.53 | SEC filing |
| 2024-10-15 | Cormorant Asset Management, LP · 10% owner | Common Shares | P — Open market or private purchase | +33,343 | 6.42 | SEC filing |
| 2024-10-15 | Cormorant Asset Management, LP · 10% owner | Common Shares | P — Open market or private purchase | +8,900 | 7.31 | SEC filing |
Showing 8 of 11 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.